Big Protection for Small Molecule Companies
New therapies developed in research institutes need protections and financing. “Big Pharma” is constantly in search of new therapies for their product pipelines. Mintz meets the needs of researchers and big pharma through a cross-disciplinary approach to the industry. Colleges and universities, entrepreneurs, venture capital firms, and private and public companies, alike, look to Mintz to provide a wide spectrum of support to help them achieve their financial and business goals.Share
We know the challenges faced by researchers, developers, manufacturers, and distributors of pharmaceuticals. And we collaborate across practice areas to serve your legal and business needs.
While our intellectual property team helps innovators generate and defend patent and trademark protections, our transactional professionals focus on private and public financings, negotiating collaborative license and development agreements, monetizing royalty streams, acquisitions, and the providing of essential day-to-day guidance for public companies. Then, there are our health law professionals who help clients navigate complex government regulations related to clinical trials, pricing, reimbursement, labeling, and more. Too, we are also adept at handling the unique employment and real estate issues facing pharmaceutical companies and research institutions.
In short, whatever the need, we have a team who has handled it for a client like you and who can handle it for you.
Mintz's IP litigation team is focused on defending the hard-earned exclusive patent rights of research-driven pharmaceutical companies. Our team achieved some important early victories in Hatch-Waxman litigation. We prevailed in one of the first post-KSR ANDA trials, which resulted in the Federal Circuit’s authoritative pronouncement on the law of chemical obviousness — and raised the bar for ANDA plaintiffs.
- Approval pathways
- Product development
- Clinical research
- Advertising and promotion
- Compliance and enforcement
- FDA interactions and disputes
- Corporate transactions
- Commercial relationships
Our team has handled dozens of royalty monetization transactions. We utilize structures and terms that help our clients most effectively achieve their goals for engaging in these transactions. No two deals are the same. We're familiar with and have used different transaction terms and structures (including synthetic structures), and will discuss options with you to determine what will work best in your circumstances.
Our attorneys collaborate across practice areas and offices to provide a full range of legal services to clients in the pharmaceuticals industry.
Member / Co-chair, Product Liability Practice
San Francisco, Los Angeles
Member / Co-chair, Securities & Capital Markets Practice
Member/Managing Member, Boston Office; Chair, Corporate, Tax, Private Client & Immigration Division
News & Press
- Patent Litigation
- Hatch-Waxman / ANDA Litigation
- IPRs & Other Post-Grant Proceedings
- Licensing & Technology Transactions
- Patent Prosecution & Strategic Counseling
- FDA Regulatory
- Health Care Compliance, Fraud & Abuse, and Regulatory Counseling
- Clinical Trials & Research
- Royalty Monetization
- Data & Privacy Litigation and Investigations
- Medicare, Medicaid & Commercial Coverage & Reimbursement
- Product Liability & Complex Tort